Press Release Diranersen Results at AAIC Provide First Evidence That Targeting Tau May Slow Cognitive Decline, Signaling Momentum Toward Addressing the Full Pathobiology of Alzheimer’s Jul 14
Press Release ADDF Statement: FDA Approval of Subcutaneous Starting Dose for Leqembi Advances Alzheimer’s Care Toward Combination Therapy Future Jul 13
Press Release The Alzheimer’s Drug Discovery Foundation and The Michael J. Fox Foundation Launch $5 Million Partnership to Target Key Co-Pathologies Driving Alzheimer’s and Parkinson’s Jul 13